CD19 and lymphoma: Most importantly, when challenged in NSG mice against CD19+ RAJI lymphoma cells, CAR T cells manufactured with either the nanomatrix or paramagnetic beads mediated a comparable anti-tumor activity and displayed similar expansion kinetics, resulting in super-imposable survival curves (Figure 1E).